The use of new materials and related technologies, e.g. nanomaterials, is crucial for many innovative approaches. In order to make innovations as safe as possible for humans and the environment, it is important to consider negative impacts along the entire value chain, considering the whole material’s life cycle. The aim is to minimise potential risks for human health and the environment while maximising their safety, without stifling innovation.
The earlier safety and health issues are taken into account in the innovation process, the better these topics can be addressed during the development phase and possibly controlled through tailored adaptations/modifications in the design process (“Safety-by-Design“).
BioNanoNet Forschungsgesellschaft mbH (BNN) specialises in developing nano-related Safety-by-Design strategies and has access to key technologies for nanosafety assessment along the value chain. BNN supports the development of safer innovative products through targeted safety concepts ready to implement in real-life innovative processes. Furthermore, BNN contributes to the development of a strategic policy towards safe chemicals innovation.
- Provided by: BioNanoNet Forschungsgesellschaft mbH
- Type: Nanosafety assesment
- Applicability domain: Several industrial domains involving nanomaterials, nanotechnologies and nano-enabled products; e.g. health technologies, medicine, energy, cosmetics, chemical industry.
- Topic: Nanosafety
- Contact: Andreas Falk
- For researchers
- For industry